A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Anagyrine | CAS 486-89-5 - Request Quote

Picture of Anagyrine
SZ CAT No:SZ-A205001
CAS No
486-89-5
Mol.F.
C15H20N2O
Mol.Wt.
244.3
Inv. Status
Synthesis on demand
Rel. CAS No74195-83-8 (HCl salt) ; 905853-96-5 (hydrochloride hydrate) ; 33478-03-4 (HBr salt)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Anagyrine is chemically (7R,14R,14aR)-1,3,4,6,7,13,14,14a-Octahydro-2H,11H-7,14-methanodipyrido[1,2-a:1',2'-e][1,5]diazocin-11-one. Anagyrine is supplied with detailed characterization data compliant with regulatory guideline. Anagyrine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Anagyrine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 486-89-5

Purchase 486-89-5

Order 486-89-5

Enquire 486-89-5

price of 486-89-5

486-89-5 Supplier

486-89-5 Manufacturer

486-89-5 Exporter

buy high quality Anagyrine

Purchase Anagyrine

Anagyrine suppliers

Anagyrine manufacturers

Anagyrine price

Order Anagyrine

Enquire Anagyrine

Anagyrine cost

Anagyrine Supplier

Anagyrine Distributor

Anagyrine for Method Validation

Anagyrine Reference Standard

Anagyrine for ANDA Filing

Anagyrine for Forced Degradation Studies

Anagyrine Identification Standards

Anagyrine for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,